Molecular and structural biology are currently witnessing revolutionary developments, which are providing unprecedented insight in the mechanisms of processes catalyzed by biomacromolecules. The fundamental progress is tremendously exciting, and at the same time offers an ever more sophisticated platform to combat human diseases. This Conference will focus on three areas where progress has been spectacular, each intimately related to human disease: structural neurobiology, bacterial machines and infectious diseases, and regulation and cancer. The conference will provide examples of the use of structural knowledge to develop compounds of great therapeutic promise, and highlight how compounds designed for potential therapeutic use have tremendous value as handles to study fundamental mechanisms of action. By bringing together scientists from different backgrounds (from Academia and industry) who share a profound interest in structural and molecular biology we aim to create a setting in which the links between different disciplines will be emphasized. In addition, students and postdocs will see the similarities, differences and interactions between industry and academia, which may help in their future career choices.
More information can be found on the website.
